Korea’s ‘Big Four’ drug makers, such as Dong-A, Daewoong, Green Cross and Yuhan, have seen a whopping sales increase of 418 percent over the past 10 years, according to a report compiled by Yakup.com, a pharmaceutical information company.
The report showed that Green Cross posted 698.8 billion won in sales last year, a 1,637 percent rise from 42.6 billion won in 1999. Its revenue increased a...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.